Literature DB >> 29700055

Hot Balloon Versus Cryoballoon Ablation for Atrial Fibrillation: Lesion Characteristics and Middle-Term Outcomes.

Koichi Nagashima1, Yasuo Okumura2, Ichiro Watanabe2, Shiro Nakahara3, Yuichi Hori3, Kazuki Iso2, Ryuta Watanabe2, Masaru Arai2, Yuji Wakamatsu2, Sayaka Kurokawa2, Hiroaki Mano2, Toshiko Nakai2, Kimie Ohkubo2, Atsushi Hirayama2.   

Abstract

BACKGROUND: Hot balloon ablation (HBA) and cryoballoon ablation (CBA) were developed to simplify ablation for atrial fibrillation. Because the lesion characteristics and efficacy of these balloon modalities have not been clarified, we compared lesion characteristics and outcomes of HBA and CBA.
METHODS: Of 165 consecutive patients who underwent initial catheter ablation for atrial fibrillation, 74 propensity scorematched (37 HBA and 37 CBA) patients were included in our study.
RESULTS: Patients' clinical characteristics, including age, sex, body mass index, atrial fibrillation subtype, CHA2DS2-VASc score, and left atrial dimension, were similar between the 2 groups. Touch-up radiofrequency ablation was required for residual/dormant pulmonary vein conduction in 52% of the patients with HBA versus 24% of the patients with CBA (P=0.02) and often in the anterior aspect of the left superior pulmonary vein after HBA (41%) versus the inferior aspect of the inferior pulmonary veins after CBA (22%). HBA lesions were smaller than CBA lesions (23.8±7.9 versus 33.5±14.5 cm2; P=0.0007). Similar results were observed when lesions in each pulmonary vein were compared between groups. Twentyfour hours after the procedure, serum levels of the cardiac biomarkers, including troponin-T, creatine kinase, and creatine kinase-MB, were higher in the HBA group than in the CBA group. Atrial fibrillation recurrence did not differ between the groups within 6 (3% versus 11%; P=0.36) or 12 months (16% versus 16%; P=1.00).
CONCLUSIONS: Although HBA lesions appear to be smaller than CBA lesions, middle-term outcomes are not statistically different between these balloon modalities.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; paroxysmal atrial fibrillation; persistent atrial fibrillation

Mesh:

Year:  2018        PMID: 29700055     DOI: 10.1161/CIRCEP.117.005861

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  10 in total

Review 1.  Persistent atrial fibrillation: should we always ice the back of the left atrium?

Authors:  Kavisha Patel; Jorge Romero; Luigi Di Biase
Journal:  J Interv Card Electrophysiol       Date:  2019-07-24       Impact factor: 1.900

2.  Electroporation: The End of the Thermal Ablation Era?

Authors:  Sanjiv M Narayan; Tina Baykaner
Journal:  J Am Coll Cardiol       Date:  2019-07-23       Impact factor: 24.094

Review 3.  Innovations in atrial fibrillation ablation.

Authors:  Jitae A Kim; Khurrum Khan; Riyad Kherallah; Shamis Khan; Ishan Kamat; Owais Ulhaq; Qussay Marashly; Mihail G Chelu
Journal:  J Interv Card Electrophysiol       Date:  2022-04-11       Impact factor: 1.900

Review 4.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

5.  Effects of Hot Balloon vs. Cryoballoon Ablation for Atrial Fibrillation: A Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Xinyi Peng; Xiao Liu; Hongbo Tian; Yu Chen; Xuexun Li
Journal:  Front Cardiovasc Med       Date:  2021-12-15

6.  Impact of monitoring surface temperature during pulmonary vein isolation in a second-generation hot balloon system.

Authors:  Hiroshi Fukunaga; Yukio Sekiguchi; Sou Asano; Takahiko Nagase; Kohei Tanizaki; Jun Umemura; Junichi Nitta; Mitsuaki Isobe
Journal:  Int J Cardiol Heart Vasc       Date:  2022-02-03

7.  Left atrial posterior wall isolation in conjunction with pulmonary vein isolation using cryoballoon for treatment of persistent atrial fibrillation (PIVoTAL): study rationale and design.

Authors:  Arash Aryana; Deep K Pujara; Shelley L Allen; James H Baker; Martin A Espinosa; Eric F Buch; Uma Srivatsa; Ethan Ellis; Kevin Makati; Marcin Kowalski; Sung Lee; Thomas Tadros; Tina Baykaner; Amin Al-Ahmad; André d'Avila; Luigi Di Biase; Kaoru Okishige; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2020-10-03       Impact factor: 1.900

8.  Ablation Therapy for Persistent Atrial Fibrillation.

Authors:  Ikechukwu Ifedili; Kristina Mouksian; David Jones; Ibrahim El Masri; Mark Heckle; John Jefferies; Yehoshua C Levine
Journal:  Curr Cardiol Rev       Date:  2022

Review 9.  Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives.

Authors:  Laura Rottner; Barbara Bellmann; Tina Lin; Bruno Reissmann; Tobias Tönnis; Ruben Schleberger; Moritz Nies; Christiane Jungen; Leon Dinshaw; Niklas Klatt; Jannis Dickow; Paula Münkler; Christian Meyer; Andreas Metzner; Andreas Rillig
Journal:  Cardiol Ther       Date:  2020-01-02

10.  How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation (radiofrequency, cryo, or laser)?

Authors:  Iwanari Kawamura; Petr Neuzil; Poojita Shivamurthy; Kenji Kuroki; Jeff Lam; Daniel Musikantow; Edward Chu; Mohit K Turagam; Kentro Minami; Moritoshi Funasako; Jan Petru; Subbarao Choudry; Marc A Miller; Marie-Noelle Langan; William Whang; Srinivas R Dukkipati; Jacob S Koruth; Vivek Y Reddy
Journal:  Europace       Date:  2021-11-08       Impact factor: 5.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.